Stocks / Biotech
EXELBiotech
Exelixis Inc
$56.261d +0.2%5d -4.7%settled close · 2026-09-14
Mkt cap $11B (3/25)β 0.6452w $35–59Shares 259.7MInd. Biological Products, (No Diagnostic Substances)Nasdaq since 2000Emp. 1,077HQ Alameda, CAexelixis.com
Who’s talkingIdea Scout · free
Who’s talking about EXEL
No tracked investor commentary on EXEL yet — the corpus grows weekly.
Idea Scout tracks who’s
talking across television, podcasts, and interviews — every stance
dated to the appearance it came from.
Sign up free →
Earnings
Next report: 2 Nov 2026
Confirmed date · consensus EPS 0.84. Reactions below are the next settled session over the prior close.
The options tapeThe Brief · paid
Notable options days
Sessions in the last 120 where EXEL’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 23 of 120 sessions qualified.
The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
| Date | Close | RVOL | Δ$ flow ($M) | Call % | LEAPS % | +20 sess. |
|---|---|---|---|---|---|---|
| 2026-09-11 | ||||||
| 2026-09-01 | ||||||
| 2026-08-27 | ||||||
| 2026-08-10 | ||||||
| 2026-08-05 | ||||||
| 2026-08-03 | ||||||
| 2026-07-17 | ||||||
| 2026-07-07 | ||||||
| 2026-07-02 | ||||||
| 2026-06-24 | ||||||
| 2026-06-18 | ||||||
| 2026-05-14 | ||||||
| 2026-05-13 | ||||||
| 2026-05-12 | ||||||
| 2026-05-11 | ||||||
| 2026-05-07 | ||||||
| 2026-05-06 | ||||||
| 2026-05-05 | ||||||
| 2026-04-24 | ||||||
| 2026-04-23 | ||||||
| 2026-04-22 | ||||||
| 2026-04-21 | ||||||
| 2026-04-20 |
+20 sess. = raw price change over the following 20
sessions — not market-adjusted; the tape tells you where to look,
not what happens next.
Today’s tape on
EXEL is in this morning’s Brief.
Get The Brief — $20/mo →